P Devroey, H Tournaye, A Van Steirteghem, P Hendrix, H J Out; The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in
No takes yet. Share an insight, caveat, or question.
Devroey et al. (1998) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: